Replikun Biotech


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Replikun Biotech is a immunotherapy company founded in March 2005. The company is focused on the development and commercialization of immunotherapies to combat infectious diseases and cancer. Replikun offers licensing and collaboration opportunities based on KUNrep Vectors, its gene delivery and expression technology. The technology is underpinned by an integrated portfolio of granted and pending patent applications which comprise the KUNrep Vectors, their pharmaceutical applications and methods...Show all

Replikun Biotech is a immunotherapy company founded in March 2005. The company is focused on the development and commercialization of immunotherapies to combat infectious diseases and cancer. Replikun offers licensing and collaboration opportunities ...Show all

Company (Alive / Active)

Phone:

Fax:

PO Box 126
2138
Australia

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Replikun Biotech $0M Nov 30, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Replikun Biotech Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Etna Biotech S.r.l.

Italy
Alive / ActiveEtna Biotech headquarters, as well as R&D facilities, are located in Catania, Italy. Currently, the company also has access to R&D and production facilities in Berne, Switzerland. The existing Etna Biotech, focussing on cutting-edge research into viral vectors and virosome-based vaccines, forms the nucleus of a center of excellence in vaccinology with a very promising vaccine pipeline.Login to see details

Enzo Biochem

New York, New York, United States
IPO / Went publicEnzo Biochem is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and aims to provide reference laboratory services to the medical community. Founded in 1976, the company have concentrated on the development of enabling technologies in the areas of gene regulation and gene modification. Many of the company's technologies are applicable to the biomedical and pharmaceutical research markets, and the company are...Show allLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)